We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Results 1 to 5 of 17
Most popular |Most recent


ECJ: non-fertilised human ovum activated by parthenogenesis could be patentable

European Union - January 14 2015 The European Court of Justice recently ruled in International Stem Cell Corporation that parthenogenetically activated non-fertilised human ova are...

Jan Pieter Hustinx, Gertjan Kuipers, Tjibbe Douma.


Advocate General: the use of unfertilised human ova is patentable

European Union, Netherlands - September 10 2014 In International Stem Cell Corporation, the Advocate General of the European Court of Justice recently opined that parthenogenetically activated...

Jan Pieter Hustinx, Gertjan Kuipers, Margot Kokke.


ECJ opens door to SPCs for safeners in plant protection products

European Union, Netherlands - July 9 2014 The European Court of Justice (ECJ) has decided that a safener can fall within the definition of an 'active substance' as outlined in Articles 1.8...

Jan Pieter Hustinx, Gertjan Kuipers, Tjibbe Douma, Margot Kokke.


Highest Italian court: use of patent rights can conflict with competition rules

Italy - March 10 2014 In Italy, a remarkable judgment was rendered at the interface between competition law and patent law. According to the highest Italian administrative...

Jan Pieter Hustinx, Bart de Rijke, Gertjan Kuipers, Erik Pijnacker Hordijk, Tjibbe Douma.


AG’s opinion brings additional plant protection for safeners closer

European Union - March 10 2014 The ECJ ruled in GSK Biologics that an adjuvant that is part of a medical product, which adjuvant influences the therapeutic effects of the active...

Jan Pieter Hustinx, Gertjan Kuipers, Tjibbe Douma, Margot Kokke.